Literature DB >> 15547767

Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases.

Eduardo Zambrano1, Magdy El-Hennawy, Richard A Ehrenkranz, Daniel Zelterman, Miguel Reyes-Múgica.   

Abstract

Total parenteral nutrition (TPN)-induced liver injury is a common complication in neonates managed with newborn intensive care. In several of these cases, irreversible and even fatal liver damage may develop, with patients dying of liver failure. In spite of multiple studies over several years, the pathogenesis of TPN-induced liver damage remains poorly understood. Clinical data from 24 neonates with clinical history of receiving TPN who died at Yale-New Haven Children's Hospital and had autopsies performed, were collected by medical record review without knowledge of liver pathology findings. Liver histological sections from these patients were evaluated for multiple parameters without knowledge of the clinical course. Continuous data were analyzed by Wilcoxon signed-rank test and Mann-Whitney test, and dichotomous data by Fisher's exact test; P < 0.05 was considered significant. Different histopathological abnormalities with varying degrees of severity were observed. A progression in the severity of histopathological changes in relation to duration of TPN administration (DTPN) was found. While patients with DTPN of < 2 wk had no fibrosis or only mild degrees of fibrosis, patients with more than 6 wk of DTPN developed moderate-to-severe fibrosis. Similar results were observed for cholestasis and bile duct proliferation. We did not find significant differences for birth weight, gestational age, occurrence of necrotizing enterocolitis, sepsis, or enteral feedings between the group with normal-to-mild liver changes ( n = 16), and the group with moderate-to-severe liver changes ( n = 8). On the other hand, DTPN was significantly different between these two groups ( P = 0.008). Also, patients small for gestational age ( P = 0.003) and patients with bronchopulmonary dysplasia ( P = 0.001) were more commonly seen in the group with moderate-to-severe histopathological findings. Intracellular copper was detected in 12.5% of patients with moderate-to-severe liver changes, and was found in 50% of patients with normal-to-mild liver findings ( P = 0.04). Detection of copper from tissue sections also decreased with DTPN, being observed in 57% of patients with < 2 wk DTPN and in none of the patients with > 12 wk DTPN. Our findings confirm the known significant relationship between the duration of TPN and liver injury. While previously described associations with birth weight, gestational age, enteral feedings, necrotizing enterocolitis, and sepsis were not noted, our study suggests that poor intrauterine growth may be a significant clinical risk factor for TPN-induced liver injury. In addition, our findings suggest that copper may have a protective effect against the development of TPN-induced liver damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547767     DOI: 10.1007/s10024-001-0154-7

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  30 in total

Review 1.  Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.

Authors:  Prathima Nandivada; Sarah J Carlson; Melissa I Chang; Eileen Cowan; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

Review 2.  Role of the diet as a link between oxidative stress and liver diseases.

Authors:  Teresa Arrigo; Salvatore Leonardi; Caterina Cuppari; Sara Manti; Angela Lanzafame; Gabriella D'Angelo; Eloisa Gitto; Lucia Marseglia; Carmelo Salpietro
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  My approach to performing a perinatal or neonatal autopsy.

Authors:  H C Wainwright
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

4.  Liver disease after intensive care of premature baboons: histopathologic observations.

Authors:  Jay Kerecman; Anupamjit Mehrotra; Zachary Goodman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

5.  Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Sophie A Fillon; J Kirk Harris; Mark A Lovell; Milton J Finegold; Ronald J Sokol
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

6.  [13C]Methionine breath test to assess intestinal failure-associated liver disease.

Authors:  Debora Duro; Shimae Fitzgibbons; Clarissa Valim; Chi-Fu Jeffrey Yang; David Zurakowski; Melanie Dolan; Lori Bechard; Yong Ming Yu; Christopher Duggan; Tom Jaksic
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

7.  Growth outcomes and complications after radiologic gastrostomy in 120 children.

Authors:  Evan Cole Lewis; Bairbre Connolly; Michael Temple; Philip John; Peter G Chait; Jennifer Vaughan; Joao G Amaral
Journal:  Pediatr Radiol       Date:  2008-07-12

Review 8.  Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Authors:  Douglas G Burrin; Ken Ng; Barbara Stoll; Miguel Sáenz De Pipaón
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

Review 9.  The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2008-05-27       Impact factor: 1.827

10.  Enteral autonomy, cirrhosis, and long term transplant-free survival in pediatric intestinal failure patients.

Authors:  Brenna S Fullerton; Eric A Sparks; Amber M Hall; Christopher Duggan; Tom Jaksic; Biren P Modi
Journal:  J Pediatr Surg       Date:  2015-10-23       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.